Drug Profile
Iotrolan liposomal
Alternative Names: TLC I 16Latest Information Update: 16 Nov 1998
Price :
$50
*
At a glance
- Originator The Liposome Company
- Class Nonionic contrast media; Triiodobenzoic acids
- Mechanism of Action Emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Liver metastases
Most Recent Events
- 16 Nov 1998 No development reported - Preclinical for Liver metastases diagnosis in USA (unspecified route)
- 04 Sep 1996 Preclinical development for Liver metastases diagnosis in USA (unspecified route)